We found that T cells had a self-contained system to both fully activate and respond to vitamin D, independently of the kidneys,” they said.
The researchers hypothesized that adding a highly concentrated intravenous vitamin D metabolite to existing treatments could further help people recover from COVID-19.Previous studies establish links between vitamin D’s ability to reduce the inflammation caused by T cells and the severity of COVID-19.“[I]t’s crucially important to note that this study did not test vitamin D treatment in people but analyzed lung cells from eight people who had severe COVID-19,” said Dr.Even more, the mechanism for how vitamin D affects COVID-19 is still unknown,” he said.
Alcendor said that even though vitamin D is known to have immune-modulatory functions, it does not justify its use as a protective measure against COVID-19 infection, especially if one ignores COVID-19 mitigation practices.
The study suggests that vitamin D could be a therapeutic option for COVID-19 thanks to its role in hyper-inflammation.“This study reveals a potentially unique role that vitamin D plays in the activation of T-cell functions that regulate inflammation in COVID-19, and understanding these regulatory pathways may provide information that will lead to the development of novel therapies for the treatment of acute COVID-19,” said Dr.New research suggests that a drug for treating urea cycle disorders could prevent endoplasmic reticulum stress in people with severe COVID-19